Dyadic to participate in two upcoming investor conferences

Jupiter, fla., feb. 02, 2023 (globe newswire) -- dyadic international, inc. (“dyadic”, or the “company”) (nasdaq: dyai), a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein bioproduction and unmet clinical needs for effective, affordable and accessible biopharmaceutical products for human and animal health, today announced that its chief executive officer, mark emalfarb will be participating in the following two upcoming investor conferences.
DYAI Ratings Summary
DYAI Quant Ranking